Abstract
Erythromycin, from the macrolide group of antibiotics, inhibits bacterial protein synthesis. It is widely used as an alternate to penicillin and is one of the safest antibiotics currently in use. Besides its use as an alternate to penicillin, erythromycin is the recommended drug in many disease states. It diffuses readily into most body fluids, but only low concentrations are achieved in the spinal fluid. The oral forms are preferred though these are inactivated to varying degrees by gastric juice.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literature
Lacey, RW: Postgrad Med J 53:195, 1977 (new look at erythromycin).
Medical Letter 24:21, 1982 (choice of antimicrobials).
Nicholas, P: NY State J Med 77:2088 and 2243, 1977 (clinical pharmacology and therapeutic uses).
Olmstead, CB: Cutis 24:414 and 422, 1979 (dermatologic use).
Sanford, JP: N Engl J Med 300:654, 1979 (Legionnaire’s disease).
Symposium (on erythromycin): Scott Med J 22 (Suppl 1):349, 1977.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Tallarida, R.J. (1982). Ilosone® (Dista). In: TOP 200. Springer, New York, NY. https://doi.org/10.1007/978-1-4899-6746-6_82
Download citation
DOI: https://doi.org/10.1007/978-1-4899-6746-6_82
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4899-6748-0
Online ISBN: 978-1-4899-6746-6
eBook Packages: Springer Book Archive